Founded in 2015, ABL DIAGNOSTICS has designed, developed, manufactured, marketed and supported in France and internationally, directly or via a network of exclusive distributors in 45 countries, molecular biology diagnostic tests for detection (UltraGene®) and genotyping by DNA sequencing (DeepChek®), for infectious diseases.

These are the result of proprietary know-how acquired over the years and scientific collaborations with renowned teams and dedicated technical protocols. ABL DIAGNOSTICS has particularly developed high-tech genotyping medical devices for chronic infectious diseases such as AIDS, viral hepatitis, tuberculosis, and also for the genotyping of SARS-CoV-2 (Covid-19), as well as other viral and bacterial targets.

ABL DIAGNOSTICS offers its customers complementary products in the patient care value chain such as sample collection kits (MediaChek®), a specialized electronic clinical file (Nadis®, installed in more than 200 hospitals in France) and me...